MGMA 2017 Annual Conference

Andrew Renda
Director, Humana Bold Goal
Humana


Dr. Andrew Renda is Humana’s Director of Bold Goal (Population Health). His work includes leading strategy, pilots, metrics, research, knowledge management tools and communications related to making progress towards Humana’s Bold Goal of improving community health by 20% by 2020. CDC’s Healthy Days survey instrument is used as the primary means of assessing population health. This is supported by clinical leading indicators, business performance metrics and a robust research agenda that drives insights on how best to improve community health. He is a published author and speaker in the fields of population health, social determinants of health and chronic disease. Previous roles have included advancing clinical models of care through development, implementation and evaluation of population health initiatives aimed at preventing and delaying progression of chronic disease. This included product and benefit design, as well as health projects ranging from messaging campaigns and self-care interventions to clinician-led disease management programs. Significant initiatives include: Chronic Condition Special Needs Plans (C-SNP), Metabolic Syndrome Support Service, Asthma and COPD disease management and self-care programs, Sleep Apnea diagnostics and management strategy, Flu and pneumonia campaign, Tobacco cessation service integration and outreach. He also serves on several Humana clinical and research committees, including: Humana’s Clinical Leadership Network, Clinical Quality Metrics Alignment Governance Committee, Comprehensive Health Insights Joint Research Governance Committees, and Humana Publication Committee. Dr. Renda has a B.S. in psychology and biology from the University of Kentucky where he was a National Science Foundation Undergraduate Fellow. He received his medical degree and a diploma in clinical psychiatry from the Royal College of Surgeons in Ireland, followed by a Masters in Public Health from Harvard University.

Sessions :